Prediction of long-term other-cause mortality in men with early-stage prostate cancer: Results from the prostate cancer outcomes study

Urology

Volumn 85, Issue 1, 2015, Pages 92-100

  Daskivich, Timothy J ^a   Fan, Kang Hsien ^b   Koyama, Tatsuki ^b   Albertsen, Peter C ^c   Goodman, Michael ^d   Hamilton, Ann S ^e   Hoffman, Richard M ^f   Stanford, Janet L ^g   Stroup, Antoinette M ^h   Litwin, Mark S ^a,i   Penson, David F ^b,j  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Education   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; PROSTATE CANCER; UNITED STATES; CAUSE OF DEATH; COMPLICATION; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; SURVIVAL RATE; TIME FACTOR;

AGED; CAUSE OF DEATH; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 84918840061     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.07.003     Document Type: Article

References (29)

1. A. Bill-Axelson, L. Holmberg, M. Ruutu SPCG-4 Investigators Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 364 2011 1708 1717
2. F.J. Fowler, C.M. McNaughton, and P.C. ALbertsen Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer JAMA 283 2000 3217 3222
3. M.J. Resnick, T. Koyama, and K.H. Fan Long-term functional outcomes after treatment for localized prostate cancer N Engl J Med 368 2013 436 445
4. J.L. Gore, L. Kwan, and S.P. Lee Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer J Natl Cancer Inst 101 2009 888 892
5. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
6. I. Thompson, J.B. Thrasher, G. Aus AUA Prostate Cancer Clinical Guideline Update Panel Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106 2131
7. J. Mohler, R.R. Bahnson, and B. Boston NCCN clinical practice guidelines in oncology: prostate cancer J Natl Compr Canc Netw 8 2010 162 200
8. A. Heidenreich, J. Bellmunt, and M. Bolla EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localized disease Eur Urol 59 2011 61 71
9. J. Walz, N. Suardi, and S.F. Shariat Accuracy of life tables in predicting overall survival in patients after radical prostatectomy BJU Int 102 2008 33 38
10. T.J. Daskivich, K. Chamie, and L. Kwan Overtreatment of men with low-risk prostate cancer and significant comorbidity Cancer 117 2011 2058 2066
11. T.J. Daskivich, F. Kang-Hsien, and T. Koyama Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer Ann Intern Med 158 2013 709 717
12. A.L. Potosky, L.C. Harlan, and J.L. Stanford Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study J Natl Cancer Inst 91 1999 1719 1724
13. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
14. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
15. S.A. Boorjian, R.J. Karnes, and L.J. Rangel Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy J Urol 179 2008 1354 1360
16. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
17. R Development Core Team R: A Language and Environment for Statistical Computing 2011 R Foundation for Statistical Computing Vienna, Austria
18. R.J. Gray cmprsk: Subdistribution Analysis of Competing Risks 2011 R package version 2.2-2
19. G.L. Lu-Yao, P.C. Albertsen, and D.F. Moore Outcomes of localized prostate cancer following conservative management JAMA 302 2009 1202 1209
20. L. Klotz, L. Zhang, and A. Lam Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126 131
21. T.J. Wilt, M.K. Brawer, and K.M. Jones Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
22. T.J. Daskivich, J. Lai, and A.W. Dick Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis Cancer 120 2014 2432 2439
23. A. Tewari, C.C. Johnson, and G. Divine Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities J Urol 171 2004 1513 1519
24. P.C. Albertsen, D.F. Moore, and W. Shih Impact of comorbidity on survival among men with localized prostate cancer J Clin Oncol 29 2011 1335 1341
25. P.C.F.D. Albertsen, B.E. Storer, T.F. Kolon, and J. Fine The impact of co-morbidity on life expectancy among men with localized prostate cancer J Urol 156 1996 127 132
26. J. Walz, A. Gallina, and F. Saad A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer J Clin Oncol 25 2007 3576 3581
27. D.F. Penson, P.C. Albertsen, and P.S. Nelson Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst 93 2001 1822 1823
28. J.L. Lund, L.C. Harlan, and K.R. Yabroff Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease Cancer Invest 28 2010 758 764
29. C.N. Klabunde, B.B. Reeve, and L.C. Harlan Do patients consistently report comorbid conditions over time?: results from the prostate cancer outcomes study Med Care 43 2005 391 400